STUDresearch · Non-peptide
Spironolactone
Also known as
Spiro · Aldactone · spironolactone topical · topical spiro · Aldactone hair
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Non-peptide
Lots of talk
Mixed
Oral / Topical
Skin, hair & tissue remodeling
Mixed — oral is whole-body (women’s hair/acne); topical DIY is a scalp experiment. Not a peptide.
What people say
Spironolactone is a prescription aldosterone antagonist with anti-androgen activity. Oral use has the established systemic drug record; topical 1–5% discussion is a separate, thinner-evidence scalp experiment.
Doses people talk about
These are reported dermatology and community ranges, not individualized instructions. Oral dose selection and potassium or renal monitoring are prescriber decisions; topical percentage does not convert to an oral dose.
How it may feel
Inspected reports conflict. One author described intense dizziness, thirst, nocturia, sleep and menstrual effects during the first 2–3 weeks, improvement around week 4 and skin or hair changes by month 3; other commenters reported no early adverse effects or stopped quickly.
Lower oral discussion25–50 mg oral daily
Described as a women's oral starting range in the preserved community notes, not a universal starting dose.
Hair or acne discussion50–100 mg oral daily
Common discussion range; the same preserved note says some clinic use extends to 150–200 mg/day under a different clinical context.
Topical DIY discussion1–5% topical
A separate scalp-solution experiment with weaker identity, stability and clinical evidence than prescription oral use.
Half-life & effect duration
- Half-life in the body
- Parent spironolactoneAbout 1.4 hours
- Active metabolite · canrenoneAbout 16.5 hours
- Active metabolite · TMSAbout 13.8 hours
- Active metabolite · HTMSAbout 15 hours
- Felt duration people report
- One accountIntense adverse effects for 2–3 weeks, improving around week 4
- Later in that accountSkin or hair changes by month 3
- Other accountsDifferent tolerability and outcomes
Cycles people discuss
Oral dermatology use is discussed as ongoing daily treatment rather than a fixed cycle. Pregnancy is a firm anti-androgen caution in the preserved profile; treatment duration and monitoring belong with the prescriber.
Timing
Oral discussion favors morning use to reduce overnight bathroom trips, with split morning/evening schedules at higher daily totals. Topical discussion instead places scalp application in the evening and says not to mix it into minoxidil; neither convention is an acne or hair-response clock.
Stacks
Oral use is commonly discussed with minoxidil or an oral contraceptive, and PCOS discussions may also mention metformin. Topical use is discussed beside minoxidil or finasteride. These are adjacent practices, not proof that a combination is superior or safe for a given person.
Access talk
Oral is prescription. Not a research peptide.
Labs people mention
Potassium and kidney panel are the ones dermatology threads actually name.
Watch for
Hyperkalemia: The oral label warns that spironolactone can cause hyperkalemia, with higher risk from impaired renal function, potassium supplements or salt substitutes, and drugs that raise potassium; it calls for serum-potassium monitoring within one week of initiation or titration and regularly thereafter.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
The label reports a 1.4-hour mean half-life for oral spironolactone; its three active metabolites are listed separately at 13.8, 15 and 16.5 hours.
In healthy volunteers, mean Tmax was 2.6 hours for spironolactone and 4.3 hours for canrenone; elimination measurements distinguish parent from canrenone, TMS and HTMS.
These label pharmacokinetics do not predict the timing of acne or hair response, an individual's diuretic symptoms, or topical-product exposure.
- DailyMed — Spironolactone tablet, film coated (opens in a new tab)Section 12.3 reports healthy-volunteer Tmax, food effect and mean elimination half-lives of 1.4 hours for spironolactone, 16.5 hours for canrenone, 13.8 hours for TMS and 15 hours for HTMS.US prescribing information covers approved oral tablets and does not establish topical exposure or a hair/acne response clock.
Felt duration people report
Inspected reports do not establish one onset or duration for diuretic, menstrual, skin or hair experiences.
One author described an intense adverse cluster for 2–3 weeks, improvement around week 4 and skin or hair changes by month 3, while other commenters reported different tolerability and outcomes.
Anonymous self-reports differ in dose, indication, co-treatments, hydration and follow-up; they cannot estimate prevalence or convert metabolite half-life into a response timeline.
- Reddit r/Spironolactone — Spironolactone Review: Bad side effects after only 5 days (opens in a new tab)The initiating author described stopping 25 mg after five days; a different commenter supplied one continuous 50-to-25 mg chronology from week 1 through month 3, while other authors reported contrasting tolerability and outcomes.Anonymous multi-author discussion; doses, indications, co-treatments and medical histories differ, and no controlled comparator or prevalence estimate is available.
What people say
- Women’s acne / shedding: Clinic and Reddit logs of less oily skin and slower female-pattern loss at 50–100 mg oral, often with OCPs. forumtrial
- PCOS hair/skin: Same drawer as metformin talk, different job. forum
- Topical male n=1s: Mixed “held the hairline” vs “nothing + itchy.” anecdote
- What talk does not prove: A male oral anti-androgen that is side-effect-free, or beating dutasteride. forum
Doses people talk about
- Women’s oral start: 25–50 mg/day. forum
- Women’s hair/acne working talk: 50–100 mg/day; some clinics 150–200 mg. forumtrial
- Men’s oral: Generally treated as a bad idea on tressless (gyno, feminization). forum
- Topical DIY: 1–5% in a scalp solution, RU-style mixing. Identity/stability weaker than RU lore. forum
- Framing: Prescription milligrams and DIY percents — not a peptide. forum
How it may feel
- Inspected early oral reports: Experiences varied from no early adverse effects to dizziness, thirst, nocturia, spotting, palpitations, sleep disruption and anxiety. One author started at 50 mg, reduced to 25 mg after a week, and said the cluster lasted about 2–3 weeks. These reports do not establish prevalence. forumanecdote
- About 4 weeks to 3 months in one report: The same author described calmer acne and oiliness by about week 4, then thinner facial hair and healthier-looking scalp hair by month 3; occasional lightheadedness and nocturia remained. This is one self-report, not a response clock. forumanecdote
- Topical: Mostly vehicle feel. forum
- Potassium / “heart skip” anxiety is why people get labs. forum
Around the dose
- Clock: Morning oral so night bathroom trips are quieter; some split AM/PM if 100 mg+ . forum
- Food / potassium-rich meals become a thread once someone posts a high-K lab. forum
- Topical: Evening scalp, not mixed into minoxidil. forum
Cycles people discuss
- Daily oral while the dermatology experiment is on. Not a blast. forum
- Pregnancy: Hard stop in every serious thread — anti-androgen. trial
Timing
- Diuretic feel is same-day. Hair is months. forum
- Measured oral pharmacokinetics: The current US label reports a mean parent half-life of 1.4 hours and mean half-lives of 16.5 hours for canrenone, 13.8 hours for TMS and 15 hours for HTMS. These active-metabolite values are bodily PK, not a hair or acne response clock. trial
More on what it is
- What most people mean: The women’s hair/acne pill that also happens to be a blood-pressure diuretic. forum
- Why it is on a peptide-adjacent map: Hair stacks. Female AGA/PCOS boards live next to min/fin talk; men ask “topical spiro instead of RU.” forum
- Oral vs topical: Oral is the evidence-ish women’s path. Topical 1–5% DIY is the “keep it on the scalp” male experiment with thinner proof. forum
- Not: Not finasteride, not spirulina, not a SARM blocker. forum
- What it is: Aldosterone antagonist and weak androgen-receptor blocker. Prescription. Not a 5-AR inhibitor. Not a peptide. trial
Stacks
- Women: + minoxidil ± oral contraceptive. The dermatology pair. forum
- + Metformin in PCOS threads. forum
- Men: topical + min/fin — oral spiro is the thing they are trying not to do. forum
Access talk
- Oral is prescription. Not a research peptide. forum
- Topical compounding exists in some derm shops; DIY powder is the forum path. forum
Labs people mention
- Potassium and kidney panel are the ones dermatology threads actually name. forum
- Blood pressure if they started it as a diuretic. forum
Storage notes
- Pills in the bottle. forum
- DIY topical: ethanol/PG like RU; stability is the unanswered question. forum
Watch for
- Dizziness, peeing, dehydration. forum
- Breast tenderness / gyno — why men avoid oral. forum
- Hyperkalemia: The oral label warns that spironolactone can cause hyperkalemia, with higher risk from impaired renal function, potassium supplements or salt substitutes, and drugs that raise potassium; it calls for serum-potassium monitoring within one week of initiation or titration and regularly thereafter. trial
- Pregnancy category talk — anti-androgen. trial
- Drug interactions (ACE/ARB, potassium, NSAIDs) in the insert people screenshot. trial
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.